Capital International Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,566
| Closed | -$1.58M | – | 306 |
|
|
2021
Q4 | $1.58M | Sell |
18,566
-272,138
| -94% | -$23.2M | 0.01% | 264 |
|
|
2021
Q3 | $27.9M | Sell |
290,704
-46,763
| -14% | -$4.48M | 0.27% | 109 |
|
|
2021
Q2 | $32.8M | Sell |
337,467
-19,907
| -6% | -$1.94M | 0.29% | 113 |
|
|
2021
Q1 | $34.8M | Sell |
357,374
-40,605
| -10% | -$3.95M | 0.32% | 111 |
|
|
2020
Q4 | $38.1M | Sell |
397,979
-7,975
| -2% | -$764K | 0.35% | 103 |
|
|
2020
Q3 | $39M | Sell |
405,954
-83,510
| -17% | -$8.03M | 0.43% | 84 |
|
|
2020
Q2 | $59.7M | Buy |
489,464
+7,068
| +1% | +$862K | 0.73% | 43 |
|
|
2020
Q1 | $41.8M | Sell |
482,396
-40,419
| -8% | -$3.5M | 0.7% | 59 |
|
|
2019
Q4 | $56.2M | Sell |
522,815
-7,969
| -2% | -$857K | 0.78% | 49 |
|
|
2019
Q3 | $47.8M | Buy |
530,784
+510,286
| +2,489% | +$46M | 0.72% | 56 |
|
|
2019
Q2 | $1.73M | Buy |
20,498
+1,348
| +7% | +$114K | 0.12% | 133 |
|
|
2019
Q1 | $1.69M | Buy |
19,150
+3,500
| +22% | +$308K | 0.2% | 96 |
|
|
2018
Q4 | $1.12M | Buy |
+15,650
| New | +$1.12M | 0.15% | 112 |
|